bioMérieux Awarded ...
FDA Clearance for Ba...
10th April 2017 Content supplied by: bioMérieux (Clinical Diagnostics)
bioMérieux Your Expert in Infectious Diseases at ECCMID 2017
Did you know bioMérieux’s at ECCMID stand 9 this year? So why not see what’s trending on our stand and prepare ahead to make the most of your visit?
bioMérieux will be showcasing their numerous innovations in four key areas of expertise:
- Sepsis Diagnostic Management
- Antimicrobial Resistance (AMR)
- Immunocompromised Testing
- Microbiology Lab Efficiency
For the latest updates visit go.biomerieux.com/biomerieux-eccmid, this mini site will be regularly updated so check back from time to time! Looking forward to meeting you at Booth #9.
bioMérieux will also be hosting an Integrated Symposium on 'Diagnostic Solutions to Address One Health Antimicrobial Resistance Challenges' on Sunday April 23rd, 16:00-18:00 in Hall I, topics will include:
- Antimicrobial resistance: a global problem, requiring global “One Health” solutions
- Are clinical diagnostic tools applicable to veterinary medicine?
- Emerging bacterial resistance common to humans and animals
- Clostridium difficile: human and animal challenges
Download the pdf brochure 'Diagnostic Solutions to Address One Health Antimicrobial Resistance Challenges' for more details
Tags:
Date Published: 10th April 2017
Source article link: View
Related news
bioMérieux Awarded Multi-year Agreement
FDA Clearance for BacT/ALERT®
bioMérieux (Clinical Diagnostics)
Address:
Marcy L'Etoile
France
Tel: +[33] 4 78 87 20 00
Related news from bioMérieux (Clinical Diagnostics)
- US FDA CLIA-waiver for BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini
- BioFire Defense Partners With BARDA
- FDA Clearance and CLIA-waiver for Fast and Innovative BIOFIRE® SPOTFIRE® POC System
- MAESTRIA™, a New Generation Microbiology Middleware Optimizes Laboratory Workflow
- VIDAS® KUBE™ - the Next-generation VIDAS® System Receives CE Marking
- FDA Breakthrough Device Designation for SPECIFIC REVEAL® Rapid AST System
- Added Medical Value with Urine Sample Results Up to 8 Hours Faster
- bioMérieux to Distribute Specific Diagnostics’ REVEAL Rapid AST System in Europe
- Enhanced BIOFIRE® Blood Culture Identification 2 (BCID2) Panel Submitted for FDA Clearance
- Spotlight on Antimicrobial Stewardship with bioMérieux
- New FDA Clearance for VITEK® MS: Expanded ID for Challenging Pathogens
- PhenoMATRIX™ for WASPLab®: AI for Sample Interpretation & Sorting
- BIOFIRE® FILMARRAY® Pneumonia Panels Gain FDA clearance and CE Marking
- bioMérieux and DIAGNOSTICS IS POWER at ECCMID 2018
- FDA Clears Identification of Mycobacteria, Nocardia and Moulds on VITEK® MS
- FDA Clearance for BacT/ALERT® VIRTUO™ Fully Automated Blood Culture System
- bioMérieux Awarded Multi-year Agreement with NHS for Bacterial Screening of Platelets
- New VITEK® MS Update Enables ID of Mycobacteria, Nocardia & Moulds
- VITEK® MS CE-Marked Database Expands to Include Mycobacteria, Nocardia and Moulds
- Lab Chooses WASPLab™ and VIRTUO™ for Full Microbiology Automation